Mativ Holdings, Inc. (NYSE:MATV - Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,020,000 shares, a decline of 65.9% from the March 15th total of 2,990,000 shares. Based on an average daily volume of 1,090,000 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.9% of the company's shares are short sold.
Mativ Stock Down 0.7 %
Mativ stock traded down $0.03 during midday trading on Friday, reaching $4.59. The stock had a trading volume of 591,954 shares, compared to its average volume of 571,949. The stock has a market capitalization of $250.02 million, a P/E ratio of -5.10, a price-to-earnings-growth ratio of 1.08 and a beta of 0.68. The firm's fifty day simple moving average is $6.45 and its 200-day simple moving average is $10.50. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.29 and a current ratio of 2.40. Mativ has a 1-year low of $4.34 and a 1-year high of $19.96.
Mativ (NYSE:MATV - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.17). The firm had revenue of $458.60 million during the quarter, compared to the consensus estimate of $472.70 million. Mativ had a negative net margin of 2.46% and a positive return on equity of 3.86%. As a group, analysts expect that Mativ will post 1.15 EPS for the current fiscal year.
Mativ Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Friday, March 14th were given a dividend of $0.10 per share. The ex-dividend date was Friday, March 14th. This represents a $0.40 dividend on an annualized basis and a yield of 8.72%. Mativ's dividend payout ratio (DPR) is -44.44%.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus upgraded shares of Mativ from a "hold" rating to a "buy" rating and cut their target price for the stock from $15.50 to $10.00 in a report on Monday, March 24th.
View Our Latest Research Report on Mativ
Hedge Funds Weigh In On Mativ
Several institutional investors and hedge funds have recently modified their holdings of MATV. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Mativ by 3.8% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,724 shares of the company's stock worth $335,000 after purchasing an additional 1,121 shares in the last quarter. Illinois Municipal Retirement Fund boosted its stake in Mativ by 5.2% in the fourth quarter. Illinois Municipal Retirement Fund now owns 32,258 shares of the company's stock valued at $352,000 after buying an additional 1,583 shares in the last quarter. Rhumbline Advisers grew its position in Mativ by 1.0% in the fourth quarter. Rhumbline Advisers now owns 169,976 shares of the company's stock valued at $1,853,000 after acquiring an additional 1,649 shares during the last quarter. MetLife Investment Management LLC raised its stake in Mativ by 5.7% during the fourth quarter. MetLife Investment Management LLC now owns 33,153 shares of the company's stock worth $361,000 after acquiring an additional 1,779 shares in the last quarter. Finally, KBC Group NV increased its position in Mativ by 93.2% during the 4th quarter. KBC Group NV now owns 4,787 shares of the company's stock worth $52,000 after purchasing an additional 2,309 shares in the last quarter. 94.95% of the stock is currently owned by institutional investors and hedge funds.
About Mativ
(
Get Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Featured Stories
Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.